Sequential Small-Molecule Therapy for Lymphocytic Cicatricial Alopecia: A Multicenter Prospective Cohort Pilot Study

    Y J Li, Guanghui Shao, Qiuwei Tao, Yuqian Li, Yizhou Wang, Qilin Zhu, Jing Zhu, Sangsang Qiu, Zhongming Li, Yanyun Wang, Xufeng Du
    New to Tofacitinib? There is a guide in the encyclopedia. Read the guide →
    Studysummary In this study, patients with active lymphocytic cicatricial alopecia showed significant improvement using a three-stage treatment regimen involving Tofacitinib, Apremilast, and Crisaborole, with 93.5% experiencing marked improvement and only three mild adverse events reported.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    8 / 8 results